Premium
PREVENTING AND TREATING BRAIN METASTASES WITH THREE FIRST‐LINE EGFR‐TYROSINE KINASE INHIBITORS IN PATIENTS WITH EGFR MUTATION‐POSITIVE ADVANCED NON‐SMALL CELL LUNG CANCER
Publication year - 2018
Publication title -
respirology
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 1.857
H-Index - 85
eISSN - 1440-1843
pISSN - 1323-7799
DOI - 10.1111/resp.13420_540
Subject(s) - medicine , lung cancer , tyrosine kinase , cancer research , mutation , oncology , tyrosine kinase inhibitor , brain metastasis , erlotinib , lung , epidermal growth factor receptor , cancer , pathology , metastasis , gene , receptor , biochemistry , chemistry
Accelerating Research
Robert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom
Address
John Eccles HouseRobert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom